SCHEMBL17654091

SCHEMBL17654091

NC1=CSNN1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL193475 0.47
SCHEMBL120273 0.41
SCHEMBL5944727 0.37
SCHEMBL14739188 0.35
SCHEMBL107641 0.33 PTK2 (1.00)
SCHEMBL108867 0.33
SCHEMBL320609 0.33 MEN1 (1.00)
SCHEMBL63148 0.33
SCHEMBL1246293 0.32 MEN1 (0.30)
Fluoride SCHEMBL20497199 0.31 MEN1 (0.89)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020242933-A1 ASPARAGINE ENDOPEPTIDASE (AEP) INHIBITORS, COMPOSITIONS, AND USES RELATED THERETO EMORY UNIVERSITY (US) 2020-12-03 WO disclosed
CN-108864203-A Nitrogenous heterocyclic ruthenium complex and its preparation method and application 广西师范学院 2018-11-23 CN disclosed
EP-3383873-A1 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2018-10-10 EP disclosed
WO-2017093299-A1 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2017-06-08 WO disclosed
CN-106795150-A 1,3,4 thiadiazole compounds and its purposes in treating cancer 阿斯利康(瑞典)有限公司 2017-05-31 CN disclosed
WO-2016054388-A1 GLUTAMINASE INHIBITORS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2016-04-07 WO disclosed